An international comparison of Retinopathy of Prematurity grading performance within the Benefits of Oxygen Saturation Targeting (BOOST) II trials. International variation in ROP grading.

Brian Fleck, Cathy Williams, Ed Juszczak, Ken Cocker, Benjamin Stenson, Brian Darlow, Shaun Dai, Glen Gole, Graham Quinn, David Wallace, Anna Ells, Susan Carden, Lucilla Butler, David Clark, James Elder, Clare Wilson, Susmito Biswas, Ayad Shafiq, Andy King, Peter BrocklehurstAlistair Fielder

Research output: Contribution to journalArticlepeer-review

Abstract / Description of output

Purpose. To investigate whether the observed international differences in ROP treatment rates within the BOOST II trials might have been caused by international variation in ROP disease grading.
Methods. Groups of BOOST II trial ophthalmologists in UK, Australia and New Zealand (ANZ), and an international reference group (INT) used a web based system to grade a selection of RetCam images of ROP acquired during the BOOST II-UK trial. Rates of decisions to treat, plus disease grading, ROP stage grading, ROP zone grading, inter-observer variation within groups and intra-observer variation within groups were measured.
Original languageEnglish
JournalEye
Early online date28 Jul 2017
DOIs
Publication statusE-pub ahead of print - 28 Jul 2017

Fingerprint

Dive into the research topics of 'An international comparison of Retinopathy of Prematurity grading performance within the Benefits of Oxygen Saturation Targeting (BOOST) II trials. International variation in ROP grading.'. Together they form a unique fingerprint.

Cite this